Tafero EM (Emtricitabine / Tenofovir Alafenamide Tablet) 25mg

Tafero EM is a prescription tablet combining emtricitabine and tenofovir alafenamide for antiviral therapy. This 25mg strength formulation supports HIV-1 management when part of a complete regimen. Store at ambient temperature and follow healthcare provider guidance. Not intended for self-diagnosis or unsupervised use.

Strength

25mg

Pack Size

30s

Storage

Ambient

Manufacturer / TM Owner

Hetero Labs Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Tafero EM is used to treat HIV-1 infection in adults and pediatric patients weighing at least 25 kg. It belongs to a class of medications called nucleoside reverse transcriptase inhibitors (NRTIs) that help reduce the amount of virus in the body. This tablet is typically prescribed alongside other antiretroviral drugs as part of combination therapy to improve immune function and lower viral load.

Side Effects

Patients taking Tafero EM may experience mild gastrointestinal effects such as nausea or diarrhea, especially when starting treatment. Some individuals report fatigue, headache, or dizziness. These effects are often temporary as the body adjusts to the medication. Regular monitoring by a healthcare professional is recommended to assess overall response and tolerability.

Precautions & Warnings

Keep Tafero EM in its original packaging and store at room temperature away from moisture and heat. Do not use if the seal is broken or the tablet appears damaged. Inform your healthcare provider about all current medications and any history of kidney or liver conditions before starting this treatment. Avoid sharing this medication with others even if symptoms are similar.

Avoid Interactions

Tafero EM may interact with other drugs that affect kidney function, such as certain anti-inflammatory medications or supplements. Combining it with nephrotoxic agents could increase the risk of adverse effects. Alcohol and grapefruit products may also influence how the body processes this medication. Always disclose all prescription, over-the-counter, and herbal products to your healthcare provider.

References

Frequently Asked Questions

Tafero EM is used to treat HIV-1 infection in adults and children weighing at least 25 kg as part of combination antiretroviral therapy.

Store Tafero EM at room temperature in a dry place, away from direct light and moisture, and keep it in the original blister pack.

Tafero EM can be taken with or without food, but consistency in timing helps maintain steady levels in the body.

Common side effects may include nausea, diarrhea, headache, fatigue, or dizziness, especially when starting treatment.

Pregnant individuals should consult their healthcare provider before using Tafero EM, as benefits and risks must be assessed individually.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.